MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells

Biochemical and Biophysical Research Communications

Volumn 463, Issue 4, 2015, Pages 954-960

  Chen, Min Bin ^a,b   Yang, Lan ^c   Lu, Pei Hua ^d   Fu, Xing Li ^e   Zhang, Yan ^b   Zhu, Ya Qun ^a   Tian, Ye ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b KUNSHAN FIRST PEOPLE S HOSPITAL AFFILIATED TO JIANGSU UNIVERSITY   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^e Jiangsu University Health Science Center   (China)

Author keywords

Ceramide and chemo sensitization; Colorectal cancer; miRNA 101; SphK1

Indexed keywords

CERAMIDE; DOXORUBICIN; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; MICRORNA 101; PACLITAXEL; SPHINGOSINE KINASE 1; ANTINEOPLASTIC AGENT; MICRORNA; MIRN101 MICRORNA, HUMAN; PHOSPHOTRANSFERASE; PRIMER DNA; SPHINGOSINE KINASE;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL GROWTH; CELL VIABILITY; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH INHIBITION; HCT116 CELL LINE; HT 29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TUMOR XENOGRAFT; ANIMAL; CELL DIVISION; COLORECTAL TUMOR; DOWN REGULATION; ENZYMOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; CELL DIVISION; COLORECTAL NEOPLASMS; DNA PRIMERS; DOWN-REGULATION; HT29 CELLS; HUMANS; MICE; MICE, SCID; MICRORNAS; PACLITAXEL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84936892210     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.06.041     Document Type: Article

References (33)

1. H.J. Schmoll, and A. Stein Colorectal cancer in 2013: towards improved drugs, combinations and patient selection Nat. Rev. Clin. Oncol. 11 2014 79 80
2. E.J. Kuipers, T. Rosch, and M. Bretthauer Colorectal cancer screening-optimizing current strategies and new directions Nat. Rev. Clin. Oncol. 10 2013 130 142
3. A. Brouquet, and B. Nordlinger Metastatic colorectal cancer outcome and fatty liver disease Nat. Rev. Gastroenterol. Hepatol. 10 2013 266 267
4. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics CA Cancer J. Clin. 64 2014 2014 9 29
5. M. Liscovitch, and Y. Lavie Cancer multidrug resistance: a review of recent drug discovery research IDrugs 5 2002 349 355
6. D. Shida, K. Takabe, D. Kapitonov, S. Milstien, and S. Spiegel Targeting SphK1 as a new strategy against cancer Curr. Drug Targets 9 2008 662 673
7. M. Vadas, P. Xia, G. McCaughan, and J. Gamble The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction? Biochim. Biophys. Acta 1781 2008 442 447
8. T. Kawamori, T. Kaneshiro, M. Okumura, S. Maalouf, A. Uflacker, J. Bielawski, Y.A. Hannun, and L.M. Obeid Role for sphingosine kinase 1 in colon carcinogenesis FASEB J. 23 2009 405 414
9. H. Du, L. Guo, F. Fang, D. Chen, A.A. Sosunov, G.M. McKhann, Y. Yan, C. Wang, H. Zhang, J.D. Molkentin, F.J. Gunn-Moore, J.P. Vonsattel, O. Arancio, J.X. Chen, and S.D. Yan Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease Nat. Med. 14 2008 1097 1105
10. A.L. Huang, M.C. Ostrowski, D. Berard, and G.L. Hager Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus Cell 27 1981 245 255
11. S. Muhammad, K. Kaur, R. Huang, Q. Zhang, P. Kaur, H.O. Yazdani, M.U. Bilal, J. Zheng, L. Zheng, and X.S. Wang MicroRNAs in colorectal cancer: Role in metastasis and clinical perspectives World J. Gastroenterol. 20 2014 17011 17019
12. A.V. Orang, and A. Barzegari MicroRNAs in colorectal cancer: from diagnosis to targeted therapy Asian Pac J. Cancer Prev. 15 2014 6989 6999
13. S. Wach, E. Nolte, A. Theil, C. Stohr, T.R. T, A. Hartmann, A. Ekici, B. Keck, H. Taubert, and B. Wullich MicroRNA profiles classify papillary renal cell carcinoma subtypes Br. J. Cancer 109 2013 714 722
14. M.B. Chen, M.X. Wei, J.Y. Han, X.Y. Wu, C. Li, J. Wang, W. Shen, and P.H. Lu MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer Cell. Signal 26 2014 102 109
15. M.B. Chen, W.X. Shen, Y. Yang, X.Y. Wu, J.H. Gu, and P.H. Lu Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell J. Cell. Physiol. 226 2010 1915 1925
16. M.B. Chen, Y. Zhang, M.X. Wei, W. Shen, X.Y. Wu, C. Yao, and P.H. Lu Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells Cell. Signal 25 2013 1993 2002
17. L. Gong, B. Yang, M. Xu, B. Cheng, X. Tang, P. Zheng, Y. Jing, and G.J. Wu Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production Cancer Chemother. Pharmacol. 73 2014 69 77
18. C.W. Chiang, Y. Huang, K.W. Leong, L.C. Chen, H.C. Chen, S.J. Chen, and C.K. Chou PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells J. Biomed. Sci. 17 2010 35
19. M.J. Dehoux, R.P. van Beneden, L. Fernandez-Celemin, P.L. Lause, and J.P. Thissen Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection FEBS Lett. 544 2003 214 217
20. M. Yamanaka, D. Shegogue, H. Pei, S. Bu, A. Bielawska, J. Bielawski, B. Pettus, Y.A. Hannun, L. Obeid, and M. Trojanowska Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation J. Biol. Chem. 279 2004 53994 54001
21. M.B. Chen, X.Y. Wu, G.Q. Tao, C.Y. Liu, J. Chen, L.Q. Wang, and P.H. Lu Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro Int. J. Cancer 131 2012 2487 2498
22. Z. Shen, L. Chen, X. Yang, Y. Zhao, E. Pier, X. Zhang, and Y. Xiong Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling? Biochim. Biophys. Acta 1833 2013 2190 2200
23. C.F. Lin, C.L. Chen, and Y.S. Lin Ceramide in apoptotic signaling and anticancer therapy Curr. Med. Chem. 13 2006 1609 1616
24. M.T. Dimanche-Boitrel, A. Rebillard, and E. Gulbins Ceramide in chemotherapy of tumors Recent Pat. Anticancer Drug Discov. 6 2011 284 293
25. C.H. Wu, C. Cao, J.H. Kim, C.H. Hsu, H.J. Wanebo, W.D. Bowen, J. Xu, and J. Marshall Trojan-horse nanotube on-command intracellular drug delivery Nano Lett. 12 2012 5475 5480
26. C. Ji, B. Yang, Y.L. Yang, S.H. He, D.S. Miao, L. He, and Z.G. Bi Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition Oncogene 29 2010 6557 6568
27. Q.Y. Zhu, Z. Wang, C. Ji, L. Cheng, Y.L. Yang, J. Ren, Y.H. Jin, Q.J. Wang, X.J. Gu, Z.G. Bi, G. Hu, and Y. Yang C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and alpha-tubulin hyperacetylation both in vitro and in vivo Cell. Death Dis. 2 2011 e117
28. T. Kawamori, W. Osta, K.R. Johnson, B.J. Pettus, J. Bielawski, T. Tanaka, M.J. Wargovich, B.S. Reddy, Y.A. Hannun, L.M. Obeid, and D. Zhou Sphingosine kinase 1 is up-regulated in colon carcinogenesis FASEB J. 20 2006 386 388
29. A. Strillacci, C. Griffoni, P. Sansone, P. Paterini, G. Piazzi, G. Lazzarini, E. Spisni, M.A. Pantaleo, G. Biasco, and V. Tomasi MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells Exp. Cell. Res. 315 2009 1439 1447
30. L.B. Frankel, J. Wen, M. Lees, M. Hoyer-Hansen, T. Farkas, A. Krogh, M. Jaattela, and A.H. Lund microRNA-101 is a potent inhibitor of autophagy EMBO J. 30 2011 4628 4641
31. L.L. Fu, X. Wen, J.K. Bao, and B. Liu MicroRNA-modulated autophagic signaling networks in cancer Int. J. Biochem. Cell. Biol. 44 2012 733 736
32. S. Varambally, Q. Cao, R.S. Mani, S. Shankar, X. Wang, B. Ateeq, B. Laxman, X. Cao, X. Jing, K. Ramnarayanan, J.C. Brenner, J. Yu, J.H. Kim, B. Han, P. Tan, C. Kumar-Sinha, R.J. Lonigro, N. Palanisamy, C.A. Maher, and A.M. Chinnaiyan Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer Science 322 2008 1695 1699
33. A. Strillacci, M.C. Valerii, P. Sansone, C. Caggiano, A. Sgromo, L. Vittori, M. Fiorentino, G. Poggioli, F. Rizzello, M. Campieri, and E. Spisni Loss of miR-101 expression promotes Wnt/beta-catenin signalling pathway activation and malignancy in colon cancer cells J. Pathol. 229 2013 379 389